Merck/Schering-Plough Zetia NDA
Executive Summary
Merck/Schering-Plough joint venture files NDA Dec. 27 for Zetia (ezetimibe) tablets for the reduction of elevated cholesterol. "Zetia is the first medicine to be submitted to the FDA for approval by Merck/Schering-Plough Pharmaceuticals," the joint venture notes. The product will be supported by three sales forces (1"The Pink Sheet" Dec. 17, 2001, p. 11)...